Page last updated: 2024-11-07

dextroamphetamine and Ambulation Disorders, Neurologic

dextroamphetamine has been researched along with Ambulation Disorders, Neurologic in 2 studies

Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duffy, L1
Cappas, E1
Scimone, A1
Schofield, PR1
Karl, T1
Vezér, T1
Kurunczi, A1
Náray, M1
Papp, A1
Nagymajtényi, L1

Other Studies

2 other studies available for dextroamphetamine and Ambulation Disorders, Neurologic

ArticleYear
Behavioral profile of a heterozygous mutant mouse model for EGF-like domain neuregulin 1.
    Behavioral neuroscience, 2008, Volume: 122, Issue:4

    Topics: Acoustic Stimulation; Adaptation, Physiological; Amino Acid Motifs; Animals; Behavior, Animal; Centr

2008
Behavioral effects of subchronic inorganic manganese exposure in rats.
    American journal of industrial medicine, 2007, Volume: 50, Issue:11

    Topics: Administration, Oral; Animals; Behavior, Animal; Dentate Gyrus; Dextroamphetamine; Gait Disorders, N

2007